BioLife Solutions

Bothell, United States Founded: 1987 • Age: 39 yrs Listed Acquired By Repligen
Tissue hypothermic storage and cryopreservation freeze media are developed.

About BioLife Solutions

BioLife Solutions is a publicly listed company based in Bothell (United States) founded in 1987, and was acquired by Repligen in July 2026. Tissue hypothermic storage and cryopreservation freeze media are developed. The company has 159 employees. BioLife Solutions has completed 6 acquisitions, including Astero Bio, PanTHERA CryoSolutions and Savsu Technologies. Its website biolifesolutions.com draws about 19 thousand monthly visits. BioLife Solutions offers products and services including CryoStor, HypoThermosol, and Thawing Systems. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Diversified and Genomics. Its legal entity is BioLife Solutions Inc. Its competitors include Quanterix, Biocare Medical and Telesis Bio; 3 of its 3 listed competitors have raised funding.

Company details

BioLife Solutions was founded in 1987 and is headquartered in Bothell, United States. Operations focus on the biotechnology sector, where hypothermic storage solutions and cryopreservation media are produced for applications in regenerative medicine, biobanking, and drug discovery. Key products include CryoStor for freezing, HypoThermosol for storage, BloodStor for blood components, and media for cell thawing, supporting research and clinical needs across these fields.

  • Headquarters Bothell, United States
  • Employees 159
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website biolifesolutions.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by Repligen (Jul 2026)
  • Legal Name Biolife Solutions, Inc.
Key Metrics
  • Annual Revenue
    $96.21 M (USD)
    28.89
    as on Dec 31, 2025
  • Net Profit
    -$14.92 M (USD)
    58.63
    as on Dec 31, 2025
  • EBITDA
    $3.61 M (USD)
    -13.81
    as on Dec 31, 2025
  • Latest Funding Round
    $10.37M (USD), Post-IPO

    Oct 2023

  • Investors
  • Employee Count
    159
  • Investments & Acquisitions
    Astero Bio

    & 5 more

  • Acquired by
    Repligen

    (Jul 2026)

Products & Services of BioLife Solutions

BioLife Solutions offers a comprehensive portfolio of products and services, including CryoStor, HypoThermosol, and Thawing Systems.

CryoStor
Freeze Media

Media for cryopreservation of biologics at low temperatures

HypoThermosol
Storage Media

Product for hypothermic storage and shipping of biologics

Thawing Systems
Thawing Equipment

Systems for precise thawing of cryogenic materials

Apps and channels of BioLife Solutions

its YouTube channel BioLife Solutions has 108 subscribers and 12 videos.

BioLife Solutions
YouTube 108 subscribers 12 videos Science & Technology
Open channel

Videos from BioLife Solutions

The most watched videos on BioLife Solutions's YouTube channel, BioLife Solutions (108 subscribers). Click a video to play it here.

BioLife's Water-Free Automated Cryobag Thawing System | ThawSTAR CB
2.6K views
CellSeal® CryoCase: The Future of CGT Storage Containers
1.2K views
ThawSTAR® Vial Thawing Systems
768 views
BioLife Solutions Bioproduction Workflow
373 views

More on BioLife Solutions.

Funding Insights of BioLife Solutions

  • Total Rounds 2
  • Last Round Post-IPO — $10.37M
  • First Round $2.6M

    (Apr 2018)

All 2 funding rounds of BioLife Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2023$10.37MPost-IPO––
–
Apr 2018$2.6MPost-IPO––
–
Valuation history

1 investors in total: 1 institutional.

Investors in BioLife Solutions

BioLife Solutions has secured backing from 1 investor. Prominent investors backing the company include Repligen.

All
InvestorDescriptionFounded YearDomainLocation
Products and services for biologic drug manufacturing are supplied.
1981repligen.comWaltham, United States
Premium access

Investor details for BioLife Solutions

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BioLife Solutions

32 people are tracked at BioLife Solutions (12 in leadership, 18 in board & advisors, 2 in team); the tracked headcount is 159.

NameRoleGroup
Aby J. Mathew
SVP & CTOLeadership
Karen Foster
VP, OperationsLeadership
Mike Pallotta
Global VP, Hardware & Electrical EngineeringLeadership
Todd Berard
VP, MarketingLeadership
Rod De Greef
Chairman And CEOLeadership
Marcus Schulz
Chief Revenue OfficerLeadership
Sarah Aebersold
Chief Human Resources OfficerLeadership
Troy Wichterman
Chief Financial OfficerLeadership
Christopher Erickson
Director Of Business Systems, Implementation & ComplianceLeadership
Matt Selley
Director Of Aseptic Formulation And Fill ManufacturingLeadership
Lindsay Newton
Vice President Of Bioprocessing OperationsLeadership
Dana D.
Director Of Information TechnologyLeadership
Joseph Schick
DirectorBoard & advisors
Andrew Hinson
DirectorBoard & advisors
Jerry E. Cooley
Scientific AdvisorBoard & advisors
Scott R. Burger
Scientific AdvisorBoard & advisors
Tim Moore
DirectorBoard & advisors
Erik Woods
Scientific AdvisorBoard & advisors
Lizabeth Cardwell
Scientific AdvisorBoard & advisors
Rachel Ellingson
DirectorBoard & advisors

12 more people are available in the full profile.

Premium access

Complete people profiles for BioLife Solutions

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of BioLife Solutions

BioLife Solutions is a publicly listed company on the NASDAQ with ticker symbol BLFS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date22 Nov 1989
  • Listed onNASDAQ: BLFS
  • Listed entityBioLife Solutions, Inc.
  • Exchange sectorHealth technology
  • ISINUS09062W2044
  • Share price$38.61 (+3.51% on the day) · 2026-10-05
  • Market capitalisation$1.89B
  • Price to earnings39.9
  • EPS (diluted, trailing year)$0.97
  • Volume (last session)4,445,978

Financials of BioLife Solutions

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$96.2M-$14.9M$3.6M
2024$74.7M-$36.1M$4.2M
2023$75.9M-$68.0M-$18.5M
2022$161.8M-$139.8M-$19.9M
2021$119.2M-$8.9M-$15.7M
Premium access

Detailed financial statements for BioLife Solutions

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioLife Solutions

BioLife Solutions has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Astero Bio, PanTHERA CryoSolutions and Savsu Technologies.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Cryopreservation platform for cells, tissues, and organs is provided.
pantheracryo.comEdmonton, Canada2018Apr 2025••••
Process and handling solutions for pharmaceutical sectors are developed.
sextonbio.comIndianapolis, United States2019Aug 2021$30M
Freezers for scientific, medical, and electronics preservation are manufactured.
stirlingultracold.comAthens, United States2009May 2021••••
Temperature-controlled storage and transportation for pharmaceuticals are provided.
scisafe.comCranbury, United States2010Sep 2020$30M
Temperature-controlled packaging solutions for shipments are designed and manufactured.
savsu.comAlbuquerque, United States2009Aug 2019••••
Tools and technologies for life science research are developed.
asterobio.comMenlo Park, United States2018Mar 2019$8M
Premium access

Complete acquisition details for BioLife Solutions

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of BioLife Solutions

11 dated milestones of BioLife Solutions across 39 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioLife Solutions is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $2.6M.
  4. Acquisition Acquires Astero Bio.
  5. Acquisition Acquires Savsu Technologies.
  6. Acquisition Acquires SciSafe.
  7. Acquisition Acquires Stirling Ultracold.
  8. Acquisition Acquires Sexton Biotechnologies.
  9. Funding Latest funding round, Post-IPO, of $10.4M.
  10. Acquisition Acquires PanTHERA CryoSolutions.
  11. Exit Acquired by Repligen.

Competitors of BioLife Solutions

BioLife Solutions has 3 listed competitors in our database, 3 of them funded. They include Quanterix, Biocare Medical and Telesis Bio.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
quanterix.com2007Cambridge, United States$99.5M141
Assay kits for ultra-sensitive biomarker detection are developed.
biocare.net1997Concord, United States$85M161
Primary antibodies and instruments for immunohistochemistry are manufactured.
telesisbio.com2013San Diego, United States$25M
Online platform offering life sciences reagents and kits
Premium access

Detailed competitors of BioLife Solutions

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BioLife Solutions

The website of BioLife Solutions (biolifesolutions.com) receives about 19.3K visits a month.

  • Monthly visits
    19.3K

    ▲ 7.7% vs previous month

Similar websites

Websites whose visitors overlap most with BioLife Solutions. Affinity shows how closely the audiences match.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as BioLife Solutions (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biolife Solutions

Premium access

Complete news archive for BioLife Solutions

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioLife Solutions

BioLife Solutions was founded in 1987 and raised its 1st funding round 31 years after it was founded.

BioLife Solutions is headquartered in Bothell, United States. It is registered at Bothell, Washington, United States.

BioLife Solutions has 159 employees.

Annual revenue of BioLife Solutions is $96.21M as on Dec 31, 2025.

BioLife Solutions was founded in 1987 and is headquartered in Bothell, United States. Operations focus on the biotechnology sector, where hypothermic storage solutions and cryopreservation media are produced for applications in regenerative medicine, biobanking, and drug discovery. Key products include CryoStor for freezing, HypoThermosol for storage, BloodStor for blood components, and media for cell thawing, supporting research and clinical needs across these fields.

BioLife Solutions's top competitors include Biocare Medical, Quanterix and Telesis Bio.

BioLife Solutions offers CryoStor, HypoThermosol, and Thawing Systems.

Yes, BioLife Solutions is publicly traded on NASDAQ under the ticker symbol BLFS.

BioLife Solutions has made 6 acquisitions, including Astero Bio, PanTHERA CryoSolutions, and Savsu Technologies.

BioLife Solutions has 1 investor. Key investors include Repligen.

BioLife Solutions operates through Biolife Solutions Inc.

Yes. BioLife Solutions was acquired by Repligen in July 2026.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available